A detailed history of Fort Washington Investment Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 65,856 shares of AMGN stock, worth $21.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
65,856
Previous 65,748 0.16%
Holding current value
$21.2 Million
Previous $20.5 Million 3.3%
% of portfolio
0.13%
Previous 0.14%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$309.38 - $337.38 $33,413 - $36,437
108 Added 0.16%
65,856 $21.2 Million
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $16.8 Million - $20.4 Million
63,769 Added 3222.28%
65,748 $20.5 Million
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $2,557 - $2,884
-10 Reduced 0.5%
1,979 $569,000
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $23,395 - $29,046
-107 Reduced 5.1%
1,989 $534,000
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $6,412 - $8,148
-28 Reduced 1.32%
2,096 $550,000
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $5,998 - $6,675
26 Added 1.24%
2,124 $517,000
Q4 2021

Feb 07, 2022

SELL
$198.88 - $227.6 $46,140 - $52,803
-232 Reduced 9.96%
2,098 $472,000
Q1 2021

May 05, 2021

SELL
$221.91 - $258.6 $953,769 - $1.11 Million
-4,298 Reduced 64.85%
2,330 $580,000
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $3.27 Million - $3.9 Million
-15,121 Reduced 69.53%
6,628 $1.52 Million
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $5.77 Million - $6.41 Million
-24,581 Reduced 53.06%
21,749 $5.53 Million
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $2.04 Million - $2.5 Million
-10,313 Reduced 18.21%
46,330 $10.9 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $3.45 Million - $4.58 Million
-18,937 Reduced 25.06%
56,643 $11.5 Million
Q4 2019

Feb 03, 2020

SELL
$189.21 - $243.2 $12.3 Million - $15.8 Million
-64,848 Reduced 46.18%
75,580 $18.2 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $1.96 Million - $2.35 Million
11,267 Added 8.72%
140,428 $27.2 Million
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $405,691 - $457,302
-2,243 Reduced 1.71%
129,161 $24.5 Million
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $1.73 Million - $2.02 Million
-9,715 Reduced 6.88%
131,404 $25.6 Million
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $1.87 Million - $2.11 Million
-10,110 Reduced 6.69%
141,119 $29.3 Million
Q2 2018

Jul 27, 2018

BUY
$166.05 - $186.51 $24,907 - $27,976
150 Added 0.1%
151,229 $27.9 Million
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $1.57 Million - $1.83 Million
-9,237 Reduced 5.76%
151,079 $25.8 Million
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $17.4 Million - $19.5 Million
103,347 Added 181.41%
160,316 $27.9 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $154,743 - $176,675
-925 Reduced 1.6%
56,969 $10.6 Million
Q2 2017

Aug 10, 2017

BUY
N/A
57,894
57,894 $9.97 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.